COSCIENS Biopharma Inc. (CSCI) — Free Cash Flow Generation Index
COSCIENS Biopharma Inc. (CSCI) has a Free Cash Flow Generation Index of 0.65x as of September 2023. Free cash flow of $94.00K represents 1% of operating cash flow ($144.00K). Explore COSCIENS Biopharma Inc. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
COSCIENS Biopharma Inc. Free Cash Flow Generation Index (2003–2022)
Historical FCF Generation Index trend for COSCIENS Biopharma Inc. across 13 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of COSCIENS Biopharma Inc..
Annual Free Cash Flow Generation for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year Free Cash Flow Generation Index for COSCIENS Biopharma Inc.. Check COSCIENS Biopharma Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.94x | $4.92 Million | $5.23 Million | $10.57K | ▲ +18.0% |
| 2021 | 0.80x | $2.20 Million | $2.75 Million | $555.99K | ▼ -7.3% |
| 2020 | 0.86x | $3.01 Million | $3.49 Million | $485.46K | ▲ +39.6% |
| 2019 | 0.62x | $416.39K | $675.29K | $3.49 | ▲ +139.7% |
| 2017 | -1.55x | $-1.94 Million | $1.25 Million | $3.20 Million | ▼ -7809.0% |
| 2016 | -0.02x | $-71.44K | $3.63 Million | $3.71 Million | ▲ +65.0% |
| 2015 | -0.06x | $-161.00K | $2.87 Million | $3.03 Million | ▲ +95.2% |
| 2014 | -1.16x | $-2.14 Million | $1.84 Million | $3.98 Million | ▲ +68.5% |
| 2013 | -3.70x | $-1.70 Million | $460.21K | $2.16 Million | ▼ -538.3% |
| 2011 | 0.84x | $668.32K | $791.62K | $123.30K | ▲ +4.2% |
| 2010 | 0.81x | $388.42K | $479.50K | $85.01K | ▲ +54.2% |
| 2006 | 0.53x | $73.86K | $140.59K | $66.73K | ▲ +158.8% |
| 2003 | -0.89x | $-48.63K | $54.42K | $103.05K | — |